Tempus
Likely to Engage tag.Highly Engaged Employees

Business Services · Illinois, United States · 1K - 5K Employees

View Company Info for Free

Overview

Headquarters

600 W Chicago Ave Ste 510, Chicago, Illi...

Phone Number

(833) 514-4187

Revenue

$1.4 Billion

Stock Symbol

TEM

Industry

Business Services Software Software Testing Healthcare Software Research & Development
ZI Rank: 3
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
9
2
3
5
5
3

About Tempus

Tempus AI, Inc. operates as a highly sophisticated technology company that sits at the modern intersection of artificial intelligence, machine learning, clinical data science, and advanced genomic diagnostics. The enterprise was founded with an ambitious institutional mission to bring the power of algorithmic computational analysis directly to the healthcare ecosystem, specifically transforming how doctors approach oncology, cardiology, neuropsychiatry, and infectious diseases. By building what has grown to become one of the largest libraries of clinical and molecular data in the world, the organization empowers medical practitioners to transition away from traditional, one-size-fits-all medical treatments and move decisively toward a highly tailored, precision-based therapeutic model. The core operational platform of the business is structured around a multi-faceted data engine that seamlessly unifies disparate fragments of patient history. The proprietary system ingests, normalizes,Read more
Tempus's Social MediaPopular SearchesTempus AI IncTempusTempus IncTempus LLCTempus Labs IncSIC Code 73,737NAICS Code 51,518Ticker NASDAQ: TEMShow more

Tempus Org Chart

PhoneEmail
JO
United States flag for contact location.

Business Development Director, Tempus Compass...

PhoneEmail
Donavan Cheng, Chief Technology Officer, Diagnostics at Tempus
United States flag for contact location.

Chief Technology Officer, Diagnostics

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
Shane Colley, Chief Technology Officer at Tempus
United States flag for contact location.

Chief Technology Officer

PhoneEmail
MB
United States flag for contact location.

Chief Operating Officer, Data & Apps

PhoneEmail
Patricia Spiller, Chief Marketing Officer at Tempus
United States flag for contact location.

Chief Marketing Officer

PhoneEmail
Natasha Esprey, Chief Information Officer at Tempus
United States flag for contact location.

Chief Information Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
DD
United States flag for contact location.

Vice President, Business Development, Ai Prod...

PhoneEmail
CA
United States flag for contact location.

Senior VP Head of Corporate Development

PhoneEmail
CS
United States flag for contact location.

Vice President, Strategic Partnerships, Ai Pr...

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
PG
United States flag for contact location.

Vice President, Area of Sales

PhoneEmail
BL
United States flag for contact location.

Vice President, Life Science Revenue Operatio...

PhoneEmail
NS
United States flag for contact location.

Vice President, Head of Market Access and Rei...

PhoneEmail
AH
United States flag for contact location.

Vice President, Customer Success (Deep 6)

PhoneEmail
JW
United States flag for contact location.

Vice President, Sales

PhoneEmail
SM
United States flag for contact location.

Vice President, Business Development, Life Sc...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Tempus your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope
Explore company insights
Get a deeper look into Tempus's structure, leadership, and market position:
Company Executives
Explore Tempus executive and leadership team.
Company Competitors
See Tempus competitors and alternatives

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Tempus is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Tempus is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Tempus.

Tempus financials insights

Gather financial insights about Tempus, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2017

Series B

$50M

Series C

$70M

2018

Series D

$80M

Series E

$110M

2019

Series F

$200M

2020

Multiple Rounds

$550M

2022

Other Financing Round

$275M

2024

Stock Offering

$410.7M

2025

Debt

$300M

See All Tempus's Financials Insights

Tempus Tech Stack

A closer look at the technologies used by Tempus

Most Recent Scoops

Project
Tempus has signed a multi-year data licensing and modeling agreement with BioNTech, expanding its roster of major pharmaceutical partners that includes AstraZeneca, GlaxoSmithKline, and Bristol Myers Squibb.
Project
Tempus has partnered with AstraZeneca to develop and deliver a foundation model aimed at predicting patient response in clinical trials, with the first version successfully delivered and accepted, and development of the next version now underway.
Product Development, Medical Research, Pharmaceuticals, Artificial Intelligence, Clinical Operations
Project
Tempus has received FDA approval for tumor-only xT CDx, enabling the migration of its entire solid tumor and DNA portfolio to unified ADLT pricing, with an estimated average selling price uplift of approximately $200, equating to approximately $85 million on an annual basis beginning in 2027.
Clinical Operations, Finance, Financial Operations
Project
Tempus has announced that its liquid biopsy product, xF, is currently under FDA review, with approval anticipated in H2 2027, and is expected to deliver an incremental average selling price lift of approximately $550, contributing to a combined revenue uplift of approximately $400 million in 2028 alongside the xT CDx approval.
Product Development
Open Position
See more scoops

Tempus News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Tempus

What is Tempus's stock symbol?
Tempus's stock symbol is TEM
What is Tempus's official website?
Tempus's official website is www.tempus.com
What is Tempus's Revenue?
Tempus's revenue is $1.4 Billion
What is Tempus's SIC code?
Tempus's SIC: 73,737
What is Tempus's NAICS code?
Tempus's NAICS: 51,518
How many employees does Tempus have?
Tempus has 1K - 5K employees
What industry does Tempus belong to?
Tempus is in the industry of: Business Services, Software, Software Testing
What is Tempus competition?
Tempus top competitors include: Flatiron, ILLUMINA, iMerit, CoverMyMeds
What companies has Tempus acquired?
Tempus has acquired the companies: The Artery Group, Progeny Software, GenomeSmart, Highline Sciences
What technology does Tempus use?
Some of the popular technologies that Tempus uses are: Freshservice, Zingfit, Qubit, DocuSign
Who is the CTO of Tempus?
Tempus's CTO is Donavan Cheng
What does Tempus do?

Tempus AI, Inc. operates as a highly sophisticated technology company that sits at the modern intersection of artificial intelligence, machine learning, clinical data science, and advanced genomic diagnostics. The enterprise was founded with an ambitious institutional mission to bring the power of algorithmic computational analysis directly to the... healthcare ecosystem, specifically transforming how doctors approach oncology, cardiology, neuropsychiatry, and infectious diseases. By building what has grown to become one of the largest libraries of clinical and molecular data in the world, the organization empowers medical practitioners to transition away from traditional, one-size-fits-all medical treatments and move decisively toward a highly tailored, precision-based therapeutic model. The core operational platform of the business is structured around a multi-faceted data engine that seamlessly unifies disparate fragments of patient history. The proprietary system ingests, normalizes, and cleans vast amounts of unstructured text from electronic health records, combining it with deep molecular sequencing data gathered from their internal, state-of-the-art laboratory facilities. This intricate integration process allows the software platform to generate comprehensive, multimodal profiles for individual patients. Through the implementation of advanced neural networks and predictive data modeling, the platform identifies invisible genetic patterns and therapeutic correlations that help clinical practitioners choose targeted therapeutics, uncover hidden diagnostic risks, and forecast how a specific tumor or pathology might react over time to diverse chemical interventions.Read More

What are Tempus social media links?
Tempus Linkedin page Tempus Twitter page Tempus Facebook page
Who invested in Tempus?
Tempus has 26 investors including T. Rowe Price, Revolution Growth, New Enterprise Associates and Shenzhen Capital Group.
Is Tempus a public company?
Yes, Tempus is a public company and is traded under the symbol TEM
See more information about Tempus

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.